-+ 0.00%
-+ 0.00%
-+ 0.00%

Derayah Financial Starts Avalon Pharma's Coverage at Buy

MT Newswires·07/17/2026 08:31:35
Listen to the news
08:31 AM EDT, 07/17/2026 (MT Newswires) -- Derayah Financial on Thursday began its coverage of pharmaceutical company Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, with a buy rating and a price target of 77.00 Saudi riyals. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)